Company / AR per Share
Immunovant, Inc. AR per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.04
FY2024
5-year range
$0.01 / $0.10
FY2021-FY2024
Trend
+594.7%
vs FY2023
Sector context
#101 of 115
Health Care
What the data says
AR per Share changed +595% YoY in FY2024, a notable deviation from the 3-year average annual change of +743%.
Based on SEC 10-K filings.
0.04 in FY2024 with a 3-year CAGR of +86.4%.
Declined from $0.10 to $0.04 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +86.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 115This company $0.04 Sector average $27.09
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, ar per share increased 594.7% year-over-year.
- Ranks #101 out of 115 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.04 | +594.7% |
| FY2023 | $0.01 | -94.9% |
| FY2022 | $0.10 | +1728.5% |
| FY2021 | $0.01 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026